MedTech Entrepreneurs (MTE)
Venture capitalGraefelfing · Pre-Seed–Series A · 5 people tracked
Find your way into MedTech Entrepreneurs (MTE)
Sign up to see every warm intro you have to MedTech Entrepreneurs (MTE)
- Paths you didn't know you had: your email and LinkedIn already hold routes to the MedTech Entrepreneurs (MTE) team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
MTE invests in the next generation of medical technologies and digital health applications at pre-seed and early stages, focusing on the convergence of digital, healthcare, and technology. It targets medical devices (classes I-III) and digital health applications with defendable IP and a clear reimbursement path, explicitly excluding pharma and biotech. The fund bridges the gap between angels and larger VC funds, aiming for high multiples with few losses. It backs academically rooted founders by supplying corporate governance guidance, deep knowledge of the German healthcare system and market access, and access to an international distribution network and key opinion leaders. Target volume is roughly EUR 50M, with checks of EUR 500k-3M per company across Europe including Israel.
Source: firm website, verified Oct 25, 2026.
Team · 5 people
from the firm's website & public directoriesFounder of various medical technology companies since the early 1990s, CEO of Invitrocue Europe since 2017 and board member of Invitrocue Singapore in oncology diagnostics. He has broad VC experience and a PhD on the international expansion of US high-tech companies in Europe.
Managing Partner with two decades of executive experience at major healthcare companies (J&J, Kimberly-Clark, 3M, GOJO) and over 15 years in C-level and shareholder roles at SMEs. An inventor of patented technologies and former managing partner in management due diligence for European PE firms, he is also an active angel investor in healthcare ventures.
Medical specialist in pharmaceutical medicine with an MBA from ETH Zurich/Boston University. He worked in marketing and clinical drug development at Ciba-Geigy and Schering-Plough, was Managing Partner at Capman Venture Capital, and has over 30 years in healthcare and life sciences executive and consulting roles.
Founder of Saint Clair Advisory, Carl advises investors, family offices and venture funds on investment and fundraising strategy, drawing on his research into Soft Due Diligence. He focuses on positioning emerging and first-time funds for capital allocation and connecting them with limited partners.
Entrepreneur, medical doctor and data scientist recognized as an expert at the intersection of AI, data, digitization and healthcare. Educated at LMU Munich and Harvard with an MBA and a Master's in Data Science, he leads initiatives in Health AI and received the Eugen-Münch Prize for healthcare innovation in 2019.
Investments · 1 tracked
founders shown can be your intro pathOther
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Orbit Health
Frequently asked questions
- What stage does MedTech Entrepreneurs (MTE) invest at?
- MedTech Entrepreneurs (MTE) invests at the Pre-Seed, Seed, Series A stages.
- What is MedTech Entrepreneurs (MTE)'s typical check size?
- MedTech Entrepreneurs (MTE) typically writes checks of $540K – $3.2M.
- What sectors does MedTech Entrepreneurs (MTE) focus on?
- MedTech Entrepreneurs (MTE) focuses on AI & Machine Learning, Digital Health, Healthtech, Medical Devices.
- Where is MedTech Entrepreneurs (MTE) located?
- MedTech Entrepreneurs (MTE) is headquartered in Graefelfing, DE.
Similar investors
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests in technology companies from seed to growth stage. Since inception it has backed over 200 companies and raised more than $1.3 billion.
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Breyer Capital is an early-stage, high-conviction investment firm with a dedicated healthcare and life sciences practice backing founders rebuilding medicine at the intersection of science, data, care delivery, and economics.
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
Future Positive Capital is a venture firm that backs entrepreneurs building companies aimed at solving universal challenges at planetary scale across science and technology.







.jpeg)

